MP34-16 COULD ADJUVANT CHEMOTHERAPY HAVE THERAPEUTIC BENEFIT AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH EQUAL TO OR GREATER THAN PT3 MUSCLE INVASIVE BLADDER CANCER?
Omura, Minami, Kikuchi, Eiji, Ogihara, Koichiro, Hakozaki, Kyohei, Fukumoto, Keishiro, Kaneko, Go, Miyazaki, Yasumasa, Tanaka, Nobuyuki, Shirotake, Suguru, Kanai, Kunimitsu, Matsumoto, Kazuhiro, NagatVolume:
197
Language:
english
Journal:
The Journal of Urology
DOI:
10.1016/j.juro.2017.02.1033
Date:
April, 2017
File:
PDF, 217 KB
english, 2017
File converter
More search results
More benefits 
